Valproic Acid News and Research

RSS
Valproic Acid is a drug used to treat epileptic seizures and bipolar disorder and to prevent migraine headaches. It is also being studied in the treatment of Kaposi sarcoma. It is a type of anticonvulsant, antimaniacal, and migraine headache prophylactic.
Substituting antiepileptic drugs may lead to increase in risk of epilepsy

Substituting antiepileptic drugs may lead to increase in risk of epilepsy

Seizure drug slows spread of uveal melanoma

Seizure drug slows spread of uveal melanoma

Long-term AED therapy may increase risk of atherosclerosis in epilepsy patients

Long-term AED therapy may increase risk of atherosclerosis in epilepsy patients

Valproic acid may increase survival for brain tumor patients

Valproic acid may increase survival for brain tumor patients

Insight into beneficial epilepsy treatments for children with autism

Insight into beneficial epilepsy treatments for children with autism

Study provides insight into effective treatments for autism spectrum disorder, seizures

Study provides insight into effective treatments for autism spectrum disorder, seizures

GSK receives FDA approval for Lamictal XR to treat partial seizures

GSK receives FDA approval for Lamictal XR to treat partial seizures

Hyperion HPN-100 phase III pivotal study for urea cycle disorders meets primary endpoint

Hyperion HPN-100 phase III pivotal study for urea cycle disorders meets primary endpoint

Matchmaker function may help cardiologists understand  the natural repair process after heart attacks

Matchmaker function may help cardiologists understand the natural repair process after heart attacks

Study examines effects of AEDs on nicotine metabolite levels in smokers

Study examines effects of AEDs on nicotine metabolite levels in smokers

Valproic acid halts vision loss in patients with retinitis pigmentosa

Valproic acid halts vision loss in patients with retinitis pigmentosa

Landmark clinical trial examines effective treatment options for childhood epilepsy

Landmark clinical trial examines effective treatment options for childhood epilepsy

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

GlaxoSmithKline's Lamictal XR Extended-Release Tablets receive FDA approval

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Hyperion Therapeutics commences enrollment in its HPN-100 episodic hepatic encephalopathy trial

Embryonic stem cells raise hope of cellular replacement therapy for liver failure

Embryonic stem cells raise hope of cellular replacement therapy for liver failure

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

Hyperion enrolls first patient in HPN-100 investigational compound clinical trial

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.